885270-23-5

Basic information

• Product Name: tert-butyl 4-amidinopiperidine-1-carboxylate
• Synonyms: tert-butyl 4-amidinopiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(aMinoiMinoMethyl)-, 1,1-diMethylethyl ester;1-Boc-4-AMidinopiperidine;1-Boc-4-piperidinamidine
• CAS NO: 885270-23-5
• Molecular Formula: C₁₁H₂₁N₃O₂
• Molecular Weight: 227.3
• Mol File: 885270-23-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 330.1±52.0 °C(Predicted)
• Appearance: /
• Density: 1.18±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 12.00±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 4-amidinopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-amidinopiperidine-1-carboxylate(885270-23-5)
• EPA Substance Registry System: tert-butyl 4-amidinopiperidine-1-carboxylate(885270-23-5)

Safety Data

• Hazardous Substances Data: 885270-23-5(Hazardous Substances Data)

Usage

General Description

Tert-butyl 4-amidinopiperidine-1-carboxylate is a chemical compound with the molecular formula C12H24N4O2. It is a derivative of piperidine and is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals and agricultural chemicals. tert-Butyl 4-amidinopiperidine-1-carboxylate is known for its role as a precursor in the synthesis of other biologically active molecules, and it has been studied for its potential therapeutic applications. Tert-butyl 4-amidinopiperidine-1-carboxylate is considered to be a valuable intermediate in medicinal chemistry and drug development.

InChI:InChI=1S/C11H21N3O2/c1-11(2,3)16-10(15)14-6-4-8(5-7-14)9(12)13/h8H,4-7H2,1-3H3,(H3,12,13)

Upstream product

• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 91419-48-6 4-carbamoyl-piperidine-1-carboxylic acid tert-butyl ester 
• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 1421065-40-8 4-(N-hydroxycarbamimidoyl)piperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 1433178-86-9 benzyl 4-[5-(1,3-benzothiazol-2-yl)-4-chloro-6-hydroxypyrimidin-2-yl]piperidine-1-carboxylate 
• 1433178-90-5 benzyl 4-[5-(1,3-benzothiazol-2-yl)-4-[[(3R)-1-[(tert-butoxy)carbonyl]piperidin-3-yl]amino]-6-oxo-1,6-dihydropyrimidin-2-yl]piperidine-1-carboxylate 

Relevant articles and documents

General Ser/Thr Kinases Pharmacophore Approach for Selective Kinase Inhibitors Search as Exemplified by Design of Potent and Selective Aurora A Inhibitors

A general pharmachophore model for various types of Ser/Thr kinases was developed. Search for the molecules fitting to this pharmacophore among ASINEX proprietary library revealed a number of compounds, which were tested and appeared to possess some activity against several Ser/Thr kinases such as Aurora A, Aurora B and Haspin. The possibility of performing the fine-tuning of the general Ser/Thr pharmacophore to desired types of kinase to get active and selective inhibitors was exemplified by Aurora A kinase. As a result, several hits in 3–5?nm range of activity against Aurora A kinase with rather good selectivity and ADME properties were obtained.

NOVEL KINASE INHIBITORS

The present invention provides derivatives of thiazolylamino-substituted heterocycles. These compounds are inhibitors of kinases, including compounds that show antiproliferative activity against cells, including against tumor cells, and are useful in the treatment of diseases including cancer.

P70 S6 KINASE INHIBITORS

The present invention provides p70 S6 kinase inhibitors of the formula: pharmaceutical formulations comprising them, and methods for their use.